Related references
Note: Only part of the references are listed.B cell-activating factor (BAFF) in children with inflammatory bowel disease
Ioana Fodor et al.
PEDIATRIC RESEARCH (2021)
ACG Clinical Guideline: Management of Irritable Bowel Syndrome
Brian E. Lacy et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2021)
B-cell activating factor (BAFF) expression is associated with Crohn's disease and can serve as a potential prognostic indicator of disease response to Infliximab treatment
Nikolaos-Panagiotis Andreou et al.
DIGESTIVE AND LIVER DISEASE (2021)
Inflammatory Bowel Diseases (IBD) and the Microbiome-Searching the Crime Scene for Clues
Mirae Lee et al.
GASTROENTEROLOGY (2021)
Increased risk of inflammatory bowel disease among patients treated with rituximab in Iceland from 2001 to 2018
Valdimar B. Kristjansson et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2021)
Th17 Cells in Inflammatory Bowel Disease: Cytokines, Plasticity, and Therapies
Junjun Zhao et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2021)
Immunoglobulin A, an Active Liaison for Host-Microbiota Homeostasis
Ahmed A. Abokor et al.
MICROORGANISMS (2021)
Faecal Calprotectin in Assessment of Mucosal Healing in Adults with Inflammatory Bowel Disease: A Meta-Analysis
Mariusz A. Bromke et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Impact of the COVID-19 pandemic on inflammatory bowel disease patients: A review of the current evidence
Marko Kumric et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2021)
New insights into the interplay between autophagy, gut microbiota and inflammatory responses in IBD
Anais Larabi et al.
AUTOPHAGY (2020)
Serum Catestatin Levels and Arterial Stiffness Parameters Are Increased in Patients with Inflammatory Bowel Disease
Piero Marin Zivkovic et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Dissecting the Heterogeneity in T-Cell Mediated Inflammation in IBD
Irma Tindemans et al.
CELLS (2020)
Serum adropin levels are reduced in patients with inflammatory bowel diseases
Darko Brnic et al.
SCIENTIFIC REPORTS (2020)
The Function and Role of the Th17/Treg Cell Balance in Inflammatory Bowel Disease
Jun-bin Yan et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2020)
Recurrent Abdominal Pain in Children: Is Colonoscopy Indicated?
Harveen K. Singh et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2019)
Clinical value of fecal calprotectin
Amanda Ricciuto et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2019)
Diagnostic value of fecal B cell activating factor in patients with abdominal discomfort
C. Xie et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2019)
Belimumab: A Review in Systemic Lupus Erythematosus
Hannah A. Blair et al.
DRUGS (2018)
From bench to bedside: fecal calprotectin in inflammatory bowel diseases clinical setting
Maria Gloria Mumolo et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Role of capsule endoscopy and fecal biomarkers in small-bowel Crohn's disease to assess remission and predict relapse
Vipul Aggarwal et al.
GASTROINTESTINAL ENDOSCOPY (2017)
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies
Siew C. Ng et al.
LANCET (2017)
Comparison of non-invasive biomarkers faecal BAFF, calprotectin and FOBT in discriminating IBS from IBD and evaluation of intestinal inflammation
Yu Fu et al.
SCIENTIFIC REPORTS (2017)
Impact of Fecal Calprotectin Measurement on Decision-making in Children with Inflammatory Bowel Disease
Wael El-Matary et al.
FRONTIERS IN PEDIATRICS (2017)
Intestinal IgA as a modulator of the gut microbiota
Shinsaku Okai et al.
GUT MICROBES (2017)
B Cell-Activating Factor (BAFF) in Inflammatory Bowel Disease: BAFFling No Longer?
Ilja Striz
DIGESTIVE DISEASES AND SCIENCES (2016)
B Cell-Activating Factor (BAFF)-Targeted B Cell Therapies in Inflammatory Bowel Diseases
Mathieu Uzzan et al.
DIGESTIVE DISEASES AND SCIENCES (2016)
B Cell-Activating Factor as a New Potential Marker in Inflammatory Bowel Disease
Peipei Zhang et al.
DIGESTIVE DISEASES AND SCIENCES (2016)
Blisibimod for treatment of systemic lupus erythematosus: with trials you become wiser
Morton A. Scheinberg et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2016)
Ulcerative Colitis Is Characterized by a Decrease in Regulatory B Cells
Xinrui Wang et al.
JOURNAL OF CROHNS & COLITIS (2016)
Signaling via the NFκB system
Simon Mitchell et al.
WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE (2016)
Detection of Small Bowel Mucosal Healing and Deep Remission in Patients With Known Small Bowel Crohn's Disease Using Biomarkers, Capsule Endoscopy, and Imaging
Uri Kopylov et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Implication of B lymphocytes in the pathogenesis of ANCA-associated vasculitides
Nicolas Dumoitier et al.
AUTOIMMUNITY REVIEWS (2015)
High Within-day Variability of Fecal Calprotectin Levels in Patients with Active Ulcerative Colitis: What Is the Best Timing for Stool Sampling?
Margalida Calafat et al.
INFLAMMATORY BOWEL DISEASES (2015)
Regulatory immune cells in regulation of intestinal inflammatory response to microbiota
M. Sun et al.
MUCOSAL IMMUNOLOGY (2015)
B-cell activating factor in the pathophysiology of multiple myeloma: a target for therapy?
P. J. Hengeveld et al.
BLOOD CANCER JOURNAL (2015)
Persistence of Autoreactive IgA-Secreting B Cells Despite Multiple Immunosuppressive Medications Including Rituximab
Yong He et al.
JAMA DERMATOLOGY (2015)
A case of tumour necrosis factor-α inhibitor- and rituximab-induced plantar pustular psoriasis that completely resolved with tocilizumab
P. Jayasekera et al.
BRITISH JOURNAL OF DERMATOLOGY (2014)
Cytokine networking of innate immunity cells: a potential target of therapy
Ilja Striz et al.
CLINICAL SCIENCE (2014)
New treatments for inflammatory rheumatic disease
Carlo Selmi et al.
IMMUNOLOGIC RESEARCH (2014)
The Role of Macrophages and Dendritic Cells in the Initiation of Inflammation in IBD
Erin C. Steinbach et al.
INFLAMMATORY BOWEL DISEASES (2014)
Plasma Cells in the Mucosa of Patients with Inflammatory Bowel Disease Produce Granzyme B and Possess Cytotoxic Activities
Maria Laura Cupi et al.
JOURNAL OF IMMUNOLOGY (2014)
Rituximab Induced Psoriasis in an Infant
Loretta Fiorillo et al.
PEDIATRIC DERMATOLOGY (2014)
Inflammatory bowel disease: Pathogenesis
Yi-Zhen Zhang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Diagnostic accuracy of EUS in differentiating mucosal versus submucosal invasion of superficial esophageal cancers: a systematic review and meta-analysis
Nirav Thosani et al.
GASTROINTESTINAL ENDOSCOPY (2012)
BAFF and innate immunity: new therapeutic targets for systemic lupus erythematosus
Fabien B. Vincent et al.
IMMUNOLOGY AND CELL BIOLOGY (2012)
A Novel IL-10-Independent Regulatory Role for B Cells in Suppressing Autoimmunity by Maintenance of Regulatory T Cells via GITR Ligand
Avijit Ray et al.
JOURNAL OF IMMUNOLOGY (2012)
Effect of Bowel Cleansing for Colonoscopy on Fecal Calprotectin Levels in Pediatric Patients
Kaija-Leena Kolho et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2012)
Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease
Luke Jostins et al.
NATURE (2012)
Recent Insights Into the Genetics of Inflammatory Bowel Disease
Judy H. Cho et al.
GASTROENTEROLOGY (2011)
Randomised placebo-controlled trial of rituximab (anti-CD20) in active ulcerative colitis
Keith Leiper et al.
GUT (2011)
Systemic Toll-Like Receptor Ligands Modify B-cell Responses in Human Inflammatory Bowel Disease
Marie McDonnell et al.
INFLAMMATORY BOWEL DISEASES (2011)
Refractory Urticarial Vasculitis as a Complication of Ulcerative Colitis Successfully Treated With Rituximab
Arun Swaminath et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2011)
Mucosal Macrophages in Intestinal Homeostasis and Inflammation
Allan McI Mowat
JOURNAL OF INNATE IMMUNITY (2011)
A case for regulatory B cells in controlling the severity of autoimmune-mediated inflammation in experimental autoimmune encephalomyelitis and multiple sclerosis
Avijit Ray et al.
JOURNAL OF NEUROIMMUNOLOGY (2011)
BAFF and selection of autoreactive B cells
Zheng Liu et al.
TRENDS IN IMMUNOLOGY (2011)
Intestinal B cell-activating factor: an indicator of non-IgE-mediated hypersensitivity reactions to food?
G. Arslan Lied et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Inflammatory bowel disease: Established and evolving considerations on its etiopathogenesis and therapy
Anja Schirbel et al.
JOURNAL OF DIGESTIVE DISEASES (2010)
Severe Ulcerative Colitis After Rituximab Therapy
Daniela S. Ardelean et al.
PEDIATRICS (2010)
A critical role for the NFkB pathway in multiple myeloma
Yulia N. Demchenko et al.
ONCOTARGET (2010)
Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies in Murine Ileitis and Progressive Ileal Crohn's Disease
Xiaonan Han et al.
GASTROENTEROLOGY (2009)
Fecal Calprotectin and Lactoferrin for the Prediction of Inflammatory Bowel Disease Relapse
Javier P. Gisbert et al.
INFLAMMATORY BOWEL DISEASES (2009)
Isoflavones regulate innate immunity and inhibit experimental colitis
Masakazu Morimoto et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)
Alterations of peripheral blood CD5+B cells in inflammatory bowel disease
Yoshiyuki Mishima et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2009)
Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: Performance of fecal lactoferrin, calprotectin, and PMN-Elastase, CRP, and clinical indices
Jost Langhorst et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Multiple signaling pathways promote B lymphocyte stimulator-dependent B-cell growth and survival
Robert T. Woodland et al.
BLOOD (2008)
Complications of pediatric colonoscopy: A five-year multicenter experience
Kalpesh Thakkar et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Exacerbation of ulcerative colitis after rituximab salvage therapy
Martin Goetz et al.
INFLAMMATORY BOWEL DISEASES (2007)
In vitro and in vivo activation induces BAFF and APRIL expression in B cells
Van Trung Chu et al.
JOURNAL OF IMMUNOLOGY (2007)
NF-κB and the immune response
M. S. Hayden et al.
ONCOGENE (2006)
A role for BLyS in the activation of innate immune cells
Sock Kyung Chang et al.
BLOOD (2006)
The role of the BAFF/APRIL system on T cell function
Fabienne Mackay et al.
SEMINARS IN IMMUNOLOGY (2006)
BAFF and APRIL as osteoclast-derived survival factors for myeloma cells: a rationale for TACl-Fc treatment in patients with multiple myeloma
M. Abe et al.
LEUKEMIA (2006)
The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications
J. Satsangi et al.
GUT (2006)
B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjogren's syndrome
Marc Ittah et al.
ARTHRITIS RESEARCH & THERAPY (2006)
The BAFF/APRIL system in systemic autoimmune diseases with a special emphasis on Sjogren's syndrome
P Szodoray et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2005)
BLyS and APRIL in rheumatoid arthritis
TM Seyler et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma
M Krumbholz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Fibroblast-like synoviocytes of mesenchymal origin express functional B cell-activating factor of the TNF family in response to proinflammatory cytokines
J Ohata et al.
JOURNAL OF IMMUNOLOGY (2005)
BAFF production by antigen-presenting cells provides T cell co-stimulation
B Huard et al.
INTERNATIONAL IMMUNOLOGY (2004)
Bowel inflammation as measured by fecal calprotectin: A link between lifestyle factors and colorectal cancer risk
A Poullis et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2004)
Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival
AJ Novak et al.
BLOOD (2004)
Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway
C Kern et al.
BLOOD (2004)
Expanded B cell population blocks regulatory T cells and exacerbates ileitis in a murine model of Crohn disease
TS Olson et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells
LG Ng et al.
JOURNAL OF IMMUNOLOGY (2004)
Expression of B-cell-activating factor of the TNF family (BAFF) and its receptors in multiple sclerosis
M Thangarajh et al.
JOURNAL OF NEUROIMMUNOLOGY (2004)
Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes
MW Boulé et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome
AJ Novak et al.
BLOOD (2004)
The uncertain glory of APRIL
JP Medema et al.
CELL DEATH AND DIFFERENTIATION (2003)
Normal B cell homeostasis requires B cell activation factor production by radiation-resistant cells
L Gorelik et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjogren's syndrome
X Mariette et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
Cutting edge: BLyS enables survival of transitional and mature B cells through distinct mediators
BL Hsu et al.
JOURNAL OF IMMUNOLOGY (2002)
Mechanism of BLyS action in B cell immunity
RKG Do et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2002)
BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF
JS Thompson et al.
SCIENCE (2001)
Cost-effectiveness of endoscopy in irritable bowel syndrome
S Suleiman et al.
ARCHIVES OF INTERNAL MEDICINE (2001)
Tumor necrosis factor (TNF) receptor superfamily member TACI is a high affinity receptor for TNF family members APRIL and BLyS
YM Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
BAFF binds to the tumor necrosis factor receptor-like molecule B cell maturation antigen and is important for maintaining the peripheral B cell population
JS Thompson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease
JA Gross et al.
NATURE (2000)
APRIL and TALL-I and receptors BCMA and TACI: system for regulating humoral immunity
G Yu et al.
NATURE IMMUNOLOGY (2000)